Preimplantation Genetic Diagnosis

Preimplantation Genetic Diagnosis, often shortened to PGD, is a laboratory testing method used during in vitro fertilization (IVF) to check embryos for specific inherited genetic conditions before transfer to the uterus. It matters because it can help some individuals and couples reduce the risk of passing on a known genetic disorder, choose embryos without a targeted mutation, and make more informed fertility decisions. In modern practice, the term PGD is often used interchangeably with or replaced by preimplantation genetic testing for monogenic disorders (PGT-M), while related testing for chromosome number problems is called preimplantation genetic testing for aneuploidy (PGT-A).

What Is Preimplantation Genetic Diagnosis?
Key Takeaways
How Preimplantation Genetic Diagnosis Works
Who PGD Is For
What PGD Means in Men's Health and Fertility
PGD vs PGT-M vs PGT-A
What PGD Can and Cannot Detect
What's Normal vs What's Not?
Benefits, Limitations, and Risks
Process and Timeline
Success Rates and What Affects Them
Male Factor Fertility Considerations
Questions to Ask Your Doctor
Common Myths and Misconceptions
Related Tests and Terms
Frequently Asked Questions
References

What Is Preimplantation Genetic Diagnosis?

Preimplantation Genetic Diagnosis is a form of embryo testing used alongside IVF. After eggs are retrieved and fertilized in the lab, embryos are allowed to develop for several days. A few cells are then biopsied from the embryo, and the DNA is analyzed for a specific inherited condition that one or both genetic parents are known to carry.

Historically, PGD referred to testing embryos for a known single-gene disorder or a structural chromosome rearrangement. Today, many fertility centers use the more precise terminology from professional societies: PGT-M for monogenic disorders and PGT-SR for structural rearrangements. Even so, many patients still search for and use the term PGD.

At a glance, PGD is not a treatment for infertility by itself. It is a testing strategy that may be added to IVF when there is a known genetic risk, such as cystic fibrosis, sickle cell disease, Huntington disease, or certain translocations.

Key Takeaways

PGD is embryo testing performed during IVF to look for a specific inherited genetic condition before embryo transfer.
The modern term is often PGT-M, while PGT-A is different and looks at chromosome number rather than a known single-gene disorder.
PGD is usually considered when one or both genetic parents carry a disease-causing variant or a structural chromosome rearrangement.
It does not guarantee pregnancy, a healthy baby, or detection of every possible genetic issue.
For men, PGD can be relevant if there is a known inherited mutation, balanced translocation, Y-chromosome issue, or severe male-factor infertility requiring IVF.
Embryo biopsy and genetic analysis are generally performed at the blastocyst stage in many modern IVF programs.
Results help identify which embryos are suitable for transfer based on the specific condition being tested.
Because interpretation can be complex, genetic counseling is an important part of the process.

How Preimplantation Genetic Diagnosis Works

PGD is built into the IVF process. It does not happen in a natural conception cycle because the embryo needs to be created and assessed in a lab before implantation.

Step-by-step overview

Ovarian stimulation: The ovaries are stimulated with medication to produce multiple eggs.
Egg retrieval: Eggs are collected in a clinic procedure.
Fertilization: Eggs are fertilized with sperm, often using intracytoplasmic sperm injection (ICSI), especially when genetic testing is planned.
Embryo culture: Embryos grow in the lab for several days, commonly to the blastocyst stage.
Embryo biopsy: A small number of cells are removed, usually from the trophectoderm, which later forms the placenta.
Genetic analysis: The sampled cells are tested for the targeted mutation or chromosome rearrangement.
Embryo freezing: Many clinics freeze embryos while waiting for results.
Embryo transfer: An embryo that does not carry the tested condition may later be transferred to the uterus.

Professional guidance from the American Society for Reproductive Medicine and the European Society of Human Reproduction and Embryology describes PGT as a specialized process that should be paired with appropriate genetic counseling and laboratory expertise.

Why biopsy timing matters

Older PGD methods often tested embryos on day 3. Many clinics now prefer blastocyst-stage biopsy because it usually provides more cells for testing and may be less disruptive to embryo development when done in experienced centers. Even so, approaches vary by clinic, diagnosis, and lab protocols.

Who PGD Is For

PGD is not used for every fertility patient. It is most relevant when there is a known, meaningful genetic risk.

Common reasons PGD may be offered

One or both partners carry a known mutation for a single-gene disorder
A prior child or pregnancy was affected by a specific inherited disease
One partner has a balanced translocation or another structural chromosome rearrangement
There is a family history of a serious inherited condition with a known causative variant
A known X-linked condition creates sex-specific genetic risk in offspring

Examples of disorders sometimes evaluated with PGD include cystic fibrosis, spinal muscular atrophy, sickle cell disease, thalassemia, Tay-Sachs disease, Fragile X-related situations in select contexts, and Huntington disease. Whether testing is appropriate depends on the exact diagnosis, inheritance pattern, and lab feasibility.

The National Library of Medicine notes that preimplantation testing is most useful when the genetic change in a family is already known.

What PGD Means in Men's Health and Fertility

For a men's health and fertility audience, PGD becomes relevant in several real-world scenarios. A man may discover during fertility evaluation that he carries a mutation linked to an inherited disease, has a structural chromosome rearrangement, or has severe sperm abnormalities associated with genetic findings.

Why male fertility patients may consider PGD

Known carrier status: If a man carries a pathogenic variant for a condition such as cystic fibrosis or sickle cell disease, and the partner also carries a relevant mutation or there is dominant inheritance, embryo testing may reduce transmission risk.
Balanced translocation: Some men with recurrent IVF failure, recurrent pregnancy loss, or abnormal semen findings are found to carry a balanced translocation. They may produce embryos with unbalanced chromosomal material, making PGT-SR relevant.
Y chromosome and azoospermia context: Certain genetic causes of severe male infertility, including some Y-chromosome microdeletions, can have implications for male offspring if sperm retrieval and ICSI are successful. Guidance from the American Urological Association and ASRM male infertility guideline highlights the importance of genetic testing in selected men with severe oligospermia or azoospermia.
Dominant inherited disease: If a man has a condition with autosomal dominant inheritance, each embryo may have a significant chance of inheriting it.

PGD does not improve sperm quality itself. It does not fix DNA fragmentation, low motility, low count, or hormonal issues. Instead, it is a tool used after sperm and eggs are used in IVF to evaluate embryos for a defined genetic concern.

Male genetic testing that may come before PGD

Karyotype testing for chromosome rearrangements
CFTR mutation testing in men with congenital bilateral absence of the vas deferens
Y-chromosome microdeletion testing in selected men with severe sperm deficiency
Targeted carrier screening or diagnostic genetic testing based on family history

These tests are separate from PGD, but they often help determine whether PGD should even be discussed.

PGD vs PGT-M vs PGT-A

One of the biggest sources of confusion is terminology. The word PGD is still widely searched, but fertility medicine has shifted toward more specific labels.

Quick comparison

Term	What it looks for	Best use case	Key point
PGD	Older umbrella term, usually for a known inherited disorder	Patient-friendly historical term	Still common in online searches and clinic language
PGT-M	Monogenic or single-gene disorders	Known mutation such as cystic fibrosis or Huntington disease	Most accurate modern term for classic PGD use
PGT-SR	Structural rearrangements	Balanced translocation or inversion in a parent	Focuses on chromosomal structure, not just single-gene disease
PGT-A	Aneuploidy, or abnormal chromosome number	Embryo chromosome screening in selected IVF cases	Different goal from PGD/PGT-M

The American College of Obstetricians and Gynecologists and ASRM both distinguish these categories. When patients say “PGD,” they may mean any of them, but medically the distinction matters.

Comparison table: PGD/PGT-M vs prenatal testing

Feature	PGD / PGT-M	Prenatal testing
When it happens	Before embryo transfer during IVF	During pregnancy
What is tested	Embryo cells in the lab	Fetus or placental tissue
Main goal	Select embryos without the targeted condition	Assess fetal genetic status after conception
Examples	PGT-M, PGT-SR	Chorionic villus sampling, amniocentesis, NIPT for some indications
Requires IVF	Yes	No

Important point: even after PGD, clinics may still recommend confirmatory prenatal testing in pregnancy because no embryo test is perfect.

What PGD Can and Cannot Detect

What PGD can detect

PGD is designed to detect a specific, known genetic issue. That may include:

A disease-causing mutation in a single gene
A parental structural chromosome rearrangement
In some programs, sex-linked risk when medically relevant

Its strength is precision. If the family mutation is known and the assay is well designed, PGD can be highly informative for that particular problem.

What PGD cannot reliably do

Guarantee a healthy baby
Detect every birth defect or every genetic condition
Eliminate miscarriage risk
Correct infertility itself
Fully predict long-term health, intelligence, or nonmedical traits

According to MedlinePlus Genetics, preimplantation testing reduces but does not remove the possibility of a genetic disorder. Testing limitations can arise from technical issues, embryo mosaicism, allele dropout, or the fact that only certain conditions are being examined.

What about embryo mosaicism?

Mosaicism means different cells within the same embryo may not all have the same chromosomal makeup. This is most commonly discussed with PGT-A rather than classic PGD for a single-gene mutation, but it can complicate interpretation in some settings. A biopsy samples only part of the embryo, so results are informative but not identical to testing every cell.

What's Normal vs What's Not?

PGD does not have a “normal range” in the way a hormone blood test or semen analysis does. Instead, results are interpreted as embryos that are affected, unaffected, carriers in some conditions, or inconclusive, depending on the inheritance pattern and testing design.

How results are commonly interpreted

Result category	What it usually means	Possible implication
Unaffected / negative for targeted mutation	The tested embryo does not carry the disease-causing variant being targeted, or is not expected to be affected based on the condition	May be eligible for transfer depending on overall embryo quality and clinic policy
Affected	The embryo carries the mutation pattern associated with the disease	Usually not selected for transfer
Carrier	The embryo carries one copy of a recessive mutation but is not expected to be affected	Transfer decisions depend on condition, counseling, and patient values
Inconclusive / no result	The lab could not make a confident determination	May not be used, or may require further discussion

What counts as acceptable for transfer can vary based on the disease, the family's goals, embryo availability, age, clinic policy, and ethical considerations.

Benefits, Limitations, and Risks

Potential benefits

May reduce the chance of passing on a known inherited disease
Can help avoid repeated affected pregnancies in some families
Allows embryo selection before pregnancy begins
May provide psychological relief for some patients facing serious hereditary risk
Can be especially useful when a parent has an autosomal dominant condition

Limitations

Requires IVF, which is invasive, time-consuming, and expensive
Not all embryos will reach biopsy stage
Not all embryos will be suitable for transfer after testing
Some cycles may result in no unaffected embryos
Testing does not eliminate the need for prenatal follow-up in many cases

Risks and burdens

Medication side effects and procedure-related risks from IVF
Emotional strain and decision fatigue
Potential for inconclusive results
Small but real possibility of misdiagnosis or technical error
Ethical and personal concerns around embryo selection

The ACOG patient guidance and GeneReviews overview of genetic counseling both emphasize the importance of pretest counseling so patients understand what the test can and cannot tell them.

Process and Timeline

From a patient perspective, PGD can feel like an added layer on top of IVF. Knowing the timeline helps set expectations.

Typical timeline

Genetic workup before IVF: The lab may need blood or saliva samples from one or both partners, and sometimes relatives, to build a custom test.
IVF stimulation and egg retrieval: This usually takes several weeks.
Embryo development: Embryos are cultured for around 5 to 7 days.
Biopsy and freezing: Biopsied embryos are commonly frozen while testing is completed.
Results review: The fertility team and genetic counselor explain which embryos are suitable for transfer.
Frozen embryo transfer: Transfer happens in a later cycle once the uterus is prepared.

In some disorders, building the custom assay for PGT-M can take additional time before the IVF cycle even begins. That is one reason early planning matters.

Success Rates and What Affects Them

There is no single success rate for PGD because outcomes depend on many factors beyond the genetic test itself. Age of the egg source, ovarian reserve, sperm quality, embryo development, the specific disease being tested, lab quality, and the number of embryos available all matter.

Factors that influence the chance of ending with a transferable embryo

Maternal age or egg age
Number of eggs retrieved
Fertilization rate
Blastocyst formation rate
The inheritance pattern of the condition
Whether the embryos also have chromosome abnormalities unrelated to the targeted disease
Sperm quality and DNA integrity

For example, if one parent has an autosomal dominant disorder, roughly half of embryos may inherit the disease-causing variant in theory, but real-life numbers can differ because not every egg becomes a usable embryo. In older patients, even unaffected embryos may also have a higher chance of aneuploidy.

This is why PGD can lower genetic risk without necessarily increasing live birth rate in every situation. The main goal is usually risk reduction for a known condition, not a blanket fertility boost.

Male Factor Fertility Considerations

Men often encounter PGD as part of a broader workup for infertility rather than as a standalone choice. If semen analysis is severely abnormal, further testing may uncover relevant genetic findings.

Situations where male factor matters

Severe oligospermia or azoospermia: These may prompt karyotype and Y-chromosome microdeletion testing under guideline-based evaluation.
Congenital absence of the vas deferens: Often associated with CFTR variants, which has reproductive and offspring implications.
Recurrent pregnancy loss: A male partner may carry a balanced translocation even if he is otherwise healthy.
Family history of inherited disease: Men who know they carry a mutation may use PGD to avoid transmission.

The AUA/ASRM male infertility guideline supports targeted genetic evaluation in selected men, especially when sperm counts are very low or absent.

Can lifestyle improve the need for PGD?

Usually no. Lifestyle changes may improve overall reproductive health, and in some men they can help semen quality, but they do not remove a known inherited mutation or a structural chromosome rearrangement. If the indication for PGD is a confirmed genetic disease risk, better sleep, exercise, supplements, or diet will not replace embryo testing.

Still, optimizing health matters before IVF

Avoid tobacco and anabolic steroids
Limit excessive alcohol
Address obesity and metabolic health
Treat varicocele or hormonal issues when appropriate
Review medications with a fertility specialist
Consider sperm DNA and advanced workup only when clinically appropriate

These steps may not change the genetic indication for PGD, but they can support better overall IVF readiness.

Questions to Ask Your Doctor

If PGD has come up in your fertility journey, these questions can help make the consultation more productive.

What exactly are we testing for: a single-gene disorder, translocation, or aneuploidy?
Do we need additional genetic counseling or carrier testing before starting?
How is the embryo biopsy performed at this clinic?
What is the chance we will have no transferable embryos?
Will embryos be frozen while waiting for results?
How often do you get inconclusive results for this type of case?
Do you recommend confirmatory prenatal testing if pregnancy occurs?
How does male factor infertility affect our chances in this cycle?
What are the total costs, including lab setup fees for custom testing?
Are there alternatives, such as natural conception with prenatal testing, donor gametes, or not testing embryos?

Common Myths and Misconceptions

Myth: PGD guarantees a healthy baby.

No test can promise that. PGD can reduce the chance of a specific inherited disorder, but it cannot rule out every medical issue or developmental outcome.

Myth: PGD and PGT-A are the same thing.

They are not. PGD usually refers to testing for a known inherited condition, while PGT-A screens for chromosome number abnormalities.

Myth: PGD improves male fertility.

It does not treat low sperm count, low motility, erectile dysfunction, hormonal imbalance, or DNA fragmentation. It is an embryo testing tool used during IVF.

Myth: If one embryo tests normal, pregnancy is guaranteed.

Implantation and ongoing pregnancy still depend on many factors, including uterine factors, embryo viability, and overall IVF success variables.

Myth: PGD is only for women.

Not at all. Men with inherited diseases, chromosome rearrangements, or severe infertility-related genetic findings may be central to the reason PGD is used.

IVF: In vitro fertilization, the process required to create embryos for PGD.
ICSI: Intracytoplasmic sperm injection, often used in IVF cycles involving genetic testing.
PGT-M: Preimplantation genetic testing for monogenic disorders.
PGT-SR: Preimplantation genetic testing for structural rearrangements.
PGT-A: Preimplantation genetic testing for aneuploidy.
Karyotype: Chromosome analysis that can detect balanced translocations and other structural changes.
Carrier screening: Testing adults to see whether they carry recessive disease-causing variants.
Y-chromosome microdeletion testing: A male infertility test used in selected cases of severe sperm deficiency.
Chorionic villus sampling and amniocentesis: Prenatal diagnostic tests that may be discussed even after PGD.

Frequently Asked Questions

Is Preimplantation Genetic Diagnosis the same as embryo screening?

Not exactly. PGD traditionally refers to testing embryos for a specific known inherited disorder. Some people use the term loosely for all embryo testing, but medically that is broader than the classic definition.

Does PGD increase IVF success rates?

Its primary purpose is to reduce the chance of passing on a known genetic condition, not to universally increase IVF success. Whether it improves outcomes depends on the situation.

Can PGD detect Down syndrome?

That question usually relates more to PGT-A, which looks at chromosome number. Classic PGD or PGT-M targets a specific inherited mutation rather than broad chromosome screening.

Can men be the reason PGD is recommended?

Yes. A male partner may carry a disease-causing variant, a balanced translocation, or another genetic finding that makes embryo testing relevant.

Is PGD 100% accurate?

No. It is highly specialized and often very informative, but no embryo test is perfect. Technical limitations and biologic factors can affect results, which is why prenatal confirmation may still be recommended.

Do you need IVF to have PGD?

Yes. PGD requires embryos to be created and tested in a laboratory before transfer, so it cannot be done in natural conception without IVF.

Can PGD tell whether an embryo is a carrier?

Often yes, depending on the condition and test design. In autosomal recessive conditions, some embryos may be unaffected carriers rather than affected.

What happens if no embryos are unaffected?

That can happen. Options may include another IVF cycle, use of donor sperm or eggs, natural conception with prenatal testing, adoption, or deciding not to pursue pregnancy. The best path depends on the diagnosis and your values.

Should prenatal testing still be done after PGD?

Many specialists recommend discussing confirmatory prenatal testing even after PGD, because embryo testing reduces risk but does not eliminate all uncertainty.